News
Updated international consensus recommendations on management of acute upper GI bleeding
October 21, 2019
Updated guidelines on management of nonvariceal acute upper GI bleeding address questions on endoscopic techniques and pharmacologic management.
News
Oral anticoagulant and PPI cotherapy cuts upper GI bleed risk
October 1, 2019
Does proton pump inhibitor (PPI) cotherapy affect the risk of upper GI bleed in patients on oral anticoagulation?
News
Hospital-acquired C. diff. tied to four ‘high-risk’ antibiotic classes
September 16, 2019
High-risk antibiotics included second-, third-, and fourth-generation cephalosporins, fluoroquinolones, carbapenems, and lincosamides.
News
Older IBD patients are most at risk of postdischarge VTE
September 10, 2019
Readmission for venous thromboembolism in patients with inflammatory bowel diseases most often occurs within 60 days of discharge.
News
Type of renal dysfunction affects liver cirrhosis mortality risk
September 4, 2019
Patients with acute on chronic kidney disease fared the worst.
News
IV fluid weaning unnecessary after gastroenteritis rehydration
August 6, 2019
SEATTLE – Saving “even a couple hours” to get kids out of the hospital quicker matters.
News
Beyond C. difficile: The future of fecal microbial transplantation
July 29, 2019
SAN DIEGO – Future directions for microbial transplantation range from multifactorial and functional gut disorders to consideration of the small intestinal microbiome.
News
Do prophylactic PPIs improve mortality in critically ill patients?
July 25, 2019
Does the use of prophylactic proton pump inhibitors improve mortality or cause more adverse events in critically ill ICU patients at high risk of gastrointestinal bleeding?
News
Rivaroxaban tied to higher GI bleeding than other NOACs
June 17, 2019
SAN DIEGO – Real-world studies comparing the GI bleeding rates among different non–vitamin K anticoagulants have been limited.
News
FDA warns about fecal microbiota for transplantation
June 17, 2019
The American Gastroenterological Association is working with physicians and patients to track FMT usage, patient outcomes, and adverse events.